{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:11Z","timestamp":1792174991481,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.surg.2025.109452","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T02:57:23Z","timestamp":1748919443000},"page":"109452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Partial adrenalectomy for pheochromocytoma in the multiple endocrine neoplasia type 2 population: Time to reconsider?"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6436-0660","authenticated-orcid":false,"given":"Diederik P.D.","family":"Suurd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medard F.M.","family":"Van den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Vi\u00ebtor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa M.","family":"Van Ginhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inne H.M.","family":"Borel Rinkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno R.","family":"Vriens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2025.109452_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.surg.2025.109452_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.surg.2025.109452_bib3","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","article-title":"Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B","volume":"91","author":"Carlson","year":"1994","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.surg.2025.109452_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-8587(18)30336-X","article-title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","volume":"7","author":"Castinetti","year":"2019","journal-title":"The Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.surg.2025.109452_bib5","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/ERC-17-0325","article-title":"Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors","volume":"25","author":"Wells","year":"2018","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.surg.2025.109452_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American thyroid association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid\u00ae"},{"key":"10.1016\/j.surg.2025.109452_bib7","doi-asserted-by":"crossref","first-page":"E336","DOI":"10.1210\/jc.2012-3192","article-title":"Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening","volume":"98","author":"Machens","year":"2013","journal-title":"The J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2025.109452_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study","volume":"15","author":"Castinetti","year":"2014","journal-title":"The Lancet Oncol"},{"key":"10.1016\/j.surg.2025.109452_bib9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/archsurg.141.12.1199","article-title":"Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A","volume":"141","author":"Asari","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.surg.2025.109452_bib10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2025.109452_bib11","first-page":"938","article-title":"Familial pheochromocytoma","volume":"94","author":"Irvin","year":"1983","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109452_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/BF01654950","article-title":"Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome","volume":"8","author":"van Heerden","year":"1984","journal-title":"World J Surg"},{"key":"10.1016\/j.surg.2025.109452_bib13","first-page":"363","article-title":"Bilateral subtotal adrenal resection for bilateral pheochromocytomas in multiple endocrine neoplasia, type IIa: a case report","volume":"98","author":"van Heerden","year":"1985","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109452_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.1057821","article-title":"Simultaneous bilateral laparoscopic cortical-sparing adrenalectomy for bilateral pheochromocytomas in multiple endocrine neoplasia type 2","volume":"9","author":"Qi","year":"2023","journal-title":"Front Surg"},{"key":"10.1016\/j.surg.2025.109452_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/life13020425","article-title":"Outcome of partial adrenalectomy in MEN2 syndrome: personal experience and systematic review of literature","volume":"13","author":"Procopio","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.surg.2025.109452_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.surg.2022.05.003","article-title":"Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate?","volume":"173","author":"Shirali","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2025.109452_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2020.02.015","article-title":"Long-term functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma","volume":"140","author":"Gomella","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.surg.2025.109452_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jamcollsurg.2012.10.012","article-title":"Long-term outcomes of surgical treatment for hereditary pheochromocytoma","volume":"216","author":"Grubbs","year":"2013","journal-title":"J Am Coll Surgeons"},{"key":"10.1016\/j.surg.2025.109452_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1464-410X.2010.09568.x","article-title":"Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas","volume":"107","author":"Sanford","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.surg.2025.109452_bib20","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1245\/s10434-008-0013-0","article-title":"Laparoscopic partial adrenalectomy for bilateral pheochromocytomas","volume":"15","author":"Cheng","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109452_bib21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/SLA.0b013e318237480c","article-title":"Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy","volume":"254","author":"Scholten","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109452_bib22","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1530\/EJE-15-0549","article-title":"Management of endocrine disease: outcome of adrenal sparing surgery in heritable pheochromocytoma","volume":"174","author":"Castinetti","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"Pt A","key":"10.1016\/j.surg.2025.109452_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijsu.2015.01.015","article-title":"Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis","volume":"16","author":"Nagaraja","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.surg.2025.109452_bib24","doi-asserted-by":"crossref","first-page":"T41","DOI":"10.1530\/ERC-17-0202","article-title":"Advances in risk-oriented surgery for multiple endocrine neoplasia type 2","volume":"25","author":"Machens","year":"2018","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.surg.2025.109452_bib25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"The Lancet"},{"key":"10.1016\/j.surg.2025.109452_bib26","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2025.109452_bib27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.surg.2025.109452_bib28","series-title":"IBM SPSS Statistics for Windows. 29.0.2.0 ed","year":"2023"},{"key":"10.1016\/j.surg.2025.109452_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109452_bib30","doi-asserted-by":"crossref","first-page":"e198898","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.surg.2025.109452_bib31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12020-022-03073-0","article-title":"Recurrent ipsilateral pheochromocytoma in carriers of RET p.Cys634 missense mutations","volume":"77","author":"Machens","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.surg.2025.109452_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ejendo\/lvae108","article-title":"PRAP study-partial versus radical adrenalectomy in hereditary pheochromocytomas","volume":"191","author":"Xu","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.surg.2025.109452_bib33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00423-016-1414-3","article-title":"Risk factors for future repeat abdominal surgery","volume":"401","author":"Strik","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.surg.2025.109452_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1245\/s10434-014-4141-4","article-title":"Development and assessment of memorial sloan kettering cancer center's surgical secondary events grading system","volume":"22","author":"Strong","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109452_bib35","article-title":"Incidence of postoperative complications is underestimated if outcome data are recorded by interns and first year residents in a low volume hospital setting","volume":"14","author":"Raguz","year":"2024","journal-title":"Scientific Rep"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025003046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606025003046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:39:35Z","timestamp":1774859975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606025003046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":35,"alternative-id":["S0039606025003046"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2025.109452","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial adrenalectomy for pheochromocytoma in the multiple endocrine neoplasia type 2 population: Time to reconsider?","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2025.109452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109452"}}